We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
+8.76%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$13.8B
AUM Growth
-$581M
(-4%)
Cap. Flow
-$2.79B
Cap. Flow
% of AUM
-20.16%
Top 10 Holdings %
Top 10 Hldgs %
25.18%
Holding
905
New
29
Increased
148
Reduced
448
Closed
194
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$66.4M |
| 2 |
Valero Energy
VLO
|
+$28.9M |
| 3 |
SLB Ltd
SLB
|
+$24.8M |
| 4 |
BNY
Bank of New York Mellon
BNY
|
+$22.6M |
| 5 |
PepsiCo
PEP
|
+$20.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$182M |
| 2 |
Apple
AAPL
|
+$148M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$90.9M |
| 4 |
Amgen
AMGN
|
+$72.1M |
| 5 |
Tesla
TSLA
|
+$66.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 31.26% |
| 2 | Technology | 28.78% |
| 3 | Financials | 8.15% |
| 4 | Consumer Discretionary | 7.54% |
| 5 | Industrials | 7.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Palantir
PLTR
$315B
| $1.2M | 0.01% |
+78,453
| New | +$892K |
|
552
Genuine Parts
GPC
$17.6B
| $1.19M | 0.01% |
7,058
-621
| -8% | -$102K |
|
553
Honeywell
HON
$77.9B
| $1.18M | 0.01% |
6,040
-154
| -2% | -$28.6K |
|
554
Steel Dynamics
STLD
$36.1B
| $1.18M | 0.01% |
10,823
-13,249
| -55% | -$1.35M |
|
555
Invesco
IVZ
$13.3B
| $1.18M | 0.01% |
70,118
-18,237
| -21% | -$294K |
|
556
Waters Corp
WAT
$36.4B
| $1.17M | 0.01% |
4,384
-5,760
| -57% | -$1.6M |
|
557
Design Therapeutics
DSGN
$742M
| $1.17M | 0.01% |
+185,000
| New | +$1.13M |
|
558
Diamondback Energy
FANG
$55.1B
| $1.15M | 0.01% |
8,769
| – | – |
|
559
Molina Healthcare
MOH
$10.4B
| $1.15M | 0.01% |
3,821
-12,252
| -76% | -$3.52M |
|
560
Best Buy
BBY
$18.6B
| $1.15M | 0.01% |
14,044
-321,082
| -96% | -$24M |
|
|
CTRA
561
DELISTED
Coterra Energy
CTRA
| $1.12M | 0.01% |
44,259
-4,301
| -9% | -$107K |
|
562
Boston Properties
BXP
$11B
| $1.1M | 0.01% |
19,142
-20,220
| -51% | -$1.05M |
|
563
Essex Property Trust
ESS
$18.7B
| $1.09M | 0.01% |
4,633
-4,611
| -50% | -$1.01M |
|
564
Sprouts Farmers Market
SFM
$7.23B
| $1.07M | 0.01% |
29,241
-406
| -1% | -$14.2K |
|
565
GoDaddy
GDDY
$12.8B
| $1.07M | 0.01% |
14,239
-4,882
| -26% | -$360K |
|
566
Bunge Global
BG
$22.8B
| $1.06M | 0.01% |
11,272
+486
| +5% | +$45.1K |
|
567
Principal Financial Group
PFG
$24B
| $1.06M | 0.01% |
13,984
-13,809
| -50% | -$995K |
|
568
Align Technology
ALGN
$12B
| $1.04M | 0.01% |
2,944
-5,383
| -65% | -$1.71M |
|
569
Sun Life Financial
SLF
$46B
| $1.03M | 0.01% |
19,790
-85,710
| -81% | -$4.21M |
|
570
Corpay
CPAY
$24.8B
| $1.03M | 0.01% |
4,090
-1,825
| -31% | -$416K |
|
571
Brookfield
BN
$103B
| $1.01M | 0.01% |
44,747
-3,330
| -7% | -$70.6K |
|
572
Teledyne Technologies
TDY
$30.2B
| $1M | 0.01% |
2,434
| – | – |
|
573
Rocket Pharmaceuticals
RCKT
$355M
| $994K | 0.01% |
50,000
| – | – |
|
574
Franklin Resources
BEN
$17.3B
| $981K | 0.01% |
36,719
-16,884
| -31% | -$436K |
|
575
Annaly Capital Management
NLY
$16.9B
| $972K | 0.01% |
48,580
-167,593
| -78% | -$3.26M |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q2 2023 Portfolio in Review
As of Q2 2023, Candriam SCA held 905 positions worth $13.8B, down 4% from $14.4B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Candriam SCA withdrew a net $2.79B in Q2 2023, closing 194 positions and reducing 448 holdings. Its most notable exit was Thomson Reuters, an estimated $19.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 31% a quarter earlier, followed by Technology and Financials.
Against the trend, Candriam SCA opened a new position in Vir Biotechnology worth $8.7M.
- Candriam SCA's largest Q2 2023 buy was Vir Biotechnology: 354,645 shares worth $8.7M.
- Candriam SCA added most to Lam Research in Q2 2023, an estimated $66.4M increase.
- Candriam SCA's biggest Q2 2023 reduction was Microsoft, cutting an estimated $182M.
- Candriam SCA fully exited Thomson Reuters in Q2 2023, selling an estimated $19.8M.
- Candriam SCA's ten largest holdings make up 25% of its $13.8B portfolio in Q2 2023.
- Candriam SCA opened 29 new positions and closed 194 in Q2 2023.
- Candriam SCA's portfolio value fell 4% quarter-over-quarter to $13.8B.
Based on Candriam SCA's 13F filing for Q2 2023, filed 8 Aug 2023.